Skip to content

DR. KATHLEEN CARNAS

Active
Private limited companyfounded 2018active for 8 yearsHikstraat(HRT) 34, 2200 Herentals, BelgiumKBO/BCE: BE 0689.750.865
Summary

DR. KATHLEEN CARNAS has been active since 2018 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €53,738 and a net result of €110,138. Equity fluctuates too strongly from year to year to read a trend from it. Its solvency ranks better than 52% of 20,700 sector peers (NACE 86, financial year 2025). The computed 12-month bankruptcy probability is below 0.1% (very low).

Overview

Official details

Source: KBO
Status
Active since 02-02-2018 Normal situation
Activity
General medical practice NACE 86210
Establishment unit
2.272.631.212 2200 Herentals, since 02-02-2018
Financial year end
31 December
Peppol
Reachable since 24-11-2023

Board and ownership

Board
  • Carnas KathleenDirector · since 02-02-2018

Financial position

94 Excellent Checked score 2025
Bankruptcy probabilitywithin 12 months
< 0.1%
Annual accounts 2025
Gross margin
€149,281
▼ 1.1%
Turnover
≈ €270,000
estimated
Profit
€110,138
▲ 0.7%
Equity
€53,738
▼ 76.8%
Total assets
€82,752
▼ 68.0%
Score breakdownlowers riskSector: Human health activities (NACE 86)Liquidity: current ratio 2.90, cash €29,508, halvedFigures for financial year 2025 (filed on 04-07-2026)Equity €53,738 (64.9% of total assets)Show the evidence

Checked score

Score 2025
94 / 100
Excellent
Probability in this band: under 0.55%
Financially stronger than 52% of micro companies in human health (NACE 86)
Financial strength · tick: 2024
Strong
Solvency 90-10
equity 64.9% of total assets
Liquidity 85-15
short-term debt 26.0% · cash 35.7%
Profitability 100=
return on assets 133.1%
Bankruptcy probability within 12 months
< 0.1% Very low
0%0.5%1.5%4%10%≥ 25%

Fewer than 1 in 1,000 comparable companies go bankrupt within 12 months (an estimate).

Sector median < 0.1% (24,160 companies, NACE 86, micro)
Last 24 months 12-2024: < 0.1% 01-2025: < 0.1%● unchanged vs 12-2024 02-2025: < 0.1%● unchanged vs 01-2025 03-2025: < 0.1%● unchanged vs 02-2025 04-2025: < 0.1%● unchanged vs 03-2025 05-2025: < 0.1%● unchanged vs 04-2025 06-2025: < 0.1%● unchanged vs 05-2025 07-2025: < 0.1%● unchanged vs 06-2025 08-2025: < 0.1%● unchanged vs 07-2025 09-2025: < 0.1%● unchanged vs 08-2025 10-2025: < 0.1%● unchanged vs 09-2025 11-2025: < 0.1%● unchanged vs 10-2025 12-2025: < 0.1%● unchanged vs 11-2025 01-2026: < 0.1%● unchanged vs 12-2025lowest value 02-2026: < 0.1%● unchanged vs 01-2026 03-2026: < 0.1%● unchanged vs 02-2026 04-2026: < 0.1%● unchanged vs 03-2026 05-2026: < 0.1%● unchanged vs 04-2026 06-2026: < 0.1%● unchanged vs 05-2026 07-2026: < 0.1%● unchanged vs 06-2026 08-2026: < 0.1%● unchanged vs 07-2026highest value 09-2026: < 0.1%● unchanged vs 08-2026highest value 10-2026: < 0.1%● unchanged vs 09-2026highest value 11-2026: < 0.1%● unchanged vs 10-2026highest value
Credit of up to €5,000 on 30-day terms is acceptable
Liquidity is ample, with a current ratio of 2.9 (9.28 in 2024), above the usual 1.5. Short-term debt is 26% and cash 35.7% of total assets. 35.1% of the assets are financed with debt and provisions.
Calculation

The band follows from the bankruptcy probability. 10 more points roughly halve it.

75-100 Excellent under 0.55%
60-74 Healthy 0.55% to 1.5%
45-59 Fair 1.5% to 4.2%
25-44 Weak 4.2% to 15.0%
0-24 Critical over 15.0%

Where the company stands within its band depends half on the bankruptcy probability and half on how it does against its sector peers (NACE 86, micro). It does better than 52% of them on solvency, 67% on liquidity, 80% on profitability and 8% on growth.

The bankruptcy probability was computed on 01-11-2026 by the bankruptcy model of 2 October 2026, which learns from Belgian bankruptcies and reads the registers, the annual accounts and the Belgian Official Gazette.

Some facts cap the score, however low the probability. With negative or zero equity, a heavy loss, a special status in the KBO, one missing filing or accounts filed more than 90 days late, the score is Fair at most (59). With two missing filings, it is Weak at most (44). During a judicial reorganisation or at the company's end (bankruptcy, dissolution, liquidation), it is Critical at most (24).

Credit check for an amount and term of your choice

Show the recommended maximum and see how the verdict changes with amount, term and advance.

The scores and ratios are Checked's own calculations, not a credit decision.

Signals

Five signals.
lowers riskneutral
lowers risk · Sector: Human health activities (NACE 86)
KBO
lowers risk · Liquidity: current ratio 2.90, cash €29,508, halved
NBB · annual accounts
lowers risk · Figures for financial year 2025 (filed on 04-07-2026)
NBB · annual accounts
lowers risk · Equity €53,738 (64.9% of total assets)
NBB · annual accounts
neutral · Latest accounts filed on time
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 04-07-2026, 27 days ahead of the deadline.
NBB · 8 filings
Deviation from the deadline
2025
27 days early
2024
42 days early
2023
28 days early
2022
14 days early
2021
30 days early
2020
37 days early
2019
1 day early
← before the deadline after the deadline →
tick = median of all Belgian filingsring = median in the sector

The company filed its last 7 accounts on average 26 days before the deadline. In the sector (NACE 86), the median for financial year 2024 was 7 days before the deadline, and 36% of those companies filed late.

Searched, nothing found (2)
neutral · Next filing not due yet
The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today. The company usually files around 4 July (5 of the last 5 accounts filed within 30 days either side of that date).
Companies Code · seven months
Where today falls in the filing period
02-11-2026 today31-12-2026 year end31-07-2027 deadline
neutral · No strike-offs in the KBO publications
That holds for every publication since 2021.
KBO publications

Key points

  • Caution: Equity fell in 2025from €231,640 to €53,738 ▼ 76.8% View
  • Positive: Always filed on timeaccounts within the deadline every year 8 years View
  • Positive: 8 profitable years in a rowprofit 2025: €110,138 8 years View

Recent changes

  1. · Gazette deed Incorporation
All 13 events

Comparable companies

These companies have the same main activity as DR. KATHLEEN CARNAS: general medical practice (NACE 86210). They are comparable in size and age: total assets between €67,400 and €96,800, founded between 2015 and 2020.

CompanyTotal assetsGross margin
DR. KATHLEEN CARNAS Herentals€82,752€149,281
Medicinet Mechelen€69,728€127,226
DOKTER ELS VAN ROMPAEY Brasschaat€70,103€155,127
Dr. Jeroen De Weirdt, huisarts Gent€67,433€140,199
Dr. Lara Beunen Aarschot€96,838€137,177
Sarah Glinne, médecine générale Thuin€96,022€158,729
Société Privée Médicale Saikali Overijse€90,516€119,362
Full comparison

Key facts about DR. KATHLEEN CARNAS

What is the company number of DR. KATHLEEN CARNAS?
The company number of DR. KATHLEEN CARNAS is 0689.750.865. The VAT number is the same number with BE in front: BE 0689.750.865.
Where is DR. KATHLEEN CARNAS based?
The registered office is at Hikstraat(HRT) 34, 2200 Herentals.Company details
What does DR. KATHLEEN CARNAS do?
According to the KBO register, the main activity is general medical practice (NACE 86210).
What is the legal form of DR. KATHLEEN CARNAS?
The legal form of DR. KATHLEEN CARNAS is Private limited company (BV).
When was DR. KATHLEEN CARNAS founded?
DR. KATHLEEN CARNAS was founded on 02-02-2018.
Is DR. KATHLEEN CARNAS still active?
Yes, DR. KATHLEEN CARNAS is an active enterprise in the KBO register.
What is the turnover of DR. KATHLEEN CARNAS?
The turnover in financial year 2025 is ≈ €270,000. This figure is estimated from the gross margin of €149,281 and 30 comparable companies (NACE 86210). It probably lies between €220,000 and €340,000.Financials
Is DR. KATHLEEN CARNAS profitable?
In financial year 2025, DR. KATHLEEN CARNAS made a profit of €110,138.
Where can I find the annual accounts of DR. KATHLEEN CARNAS?
DR. KATHLEEN CARNAS filed 8 annual accounts with the National Bank of Belgium, the latest for financial year 2025.
When are the next annual accounts of DR. KATHLEEN CARNAS due?
DR. KATHLEEN CARNAS must file the annual accounts for financial year 2026 by 31-07-2027.Timeline

Next steps

See how customers, suppliers and banks see your own company and what to improve first.

Keep this company with today's facts in a case file.